TLR9 Antikörper (N-Term)
(4 Referenzen)-
- Target Alle TLR9 Antikörper anzeigen
- TLR9 (Toll-Like Receptor 9 (TLR9))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TLR9 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC)
- Immunogen
- Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to N-terminal residues of mouse Tlr9 (Toll-like receptor 9)
- Top Product
- Discover our top product TLR9 Primärantikörper
-
anti-Toll-Like Receptor 9 (TLR9) (AA 868-1016) antibody
TLR9 Reaktivität: Human IHC, ELISA, FACS, ICC Wirt: Maus Monoclonal 1B12H2 unconjugated
anti-Toll-Like Receptor 9 (TLR9) (AA 28-362) antibodyTLR9 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Toll-Like Receptor 9 (TLR9) (AA 26-193) antibodyTLR9 Reaktivität: Human ELISA, FACS Wirt: Maus Monoclonal 5B10E8 unconjugated
anti-Toll-Like Receptor 9 (TLR9) (AA 350-450) antibodyTLR9 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Toll-Like Receptor 9 (TLR9) (AA 951-1032) antibodyTLR9 Reaktivität: Human, Maus, Ratte WB, ELISA, FACS, IHC (p), IHC (fro), IF (cc), IF (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Toll-Like Receptor 9 (TLR9) antibodyTLR9 Reaktivität: Human WB, FACS, IHC (p), IF Wirt: Maus Monoclonal 5G5 unconjugated
anti-Toll-Like Receptor 9 (TLR9) (AA 99-215) antibodyTLR9 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 1E8 unconjugated
anti-Toll-Like Receptor 9 (TLR9) (N-Term) antibodyTLR9 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Toll-Like Receptor 9 (TLR9) antibody (FITC)TLR9 Reaktivität: Human WB, FACS, IHC (p), IF Wirt: Maus Monoclonal 5G5 FITC
anti-Toll-Like Receptor 9 (TLR9) (AA 26-332) antibodyTLR9 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Lagerung
- 4 °C
-
-
: "A single base mutation in the PRAT4A gene reveals differential interaction of PRAT4A with Toll-like receptors." in: International immunology, Vol. 20, Issue 11, pp. 1407-15, (2008) (PubMed).
: "Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, Issue 10, pp. 3516-21, (2004) (PubMed).
: "Toll-like receptor 9 mediates CpG-DNA signaling." in: Journal of leukocyte biology, Vol. 71, Issue 3, pp. 538-44, (2002) (PubMed).
: "Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 16, pp. 9237-42, (2001) (PubMed).
-
: "A single base mutation in the PRAT4A gene reveals differential interaction of PRAT4A with Toll-like receptors." in: International immunology, Vol. 20, Issue 11, pp. 1407-15, (2008) (PubMed).
-
- Target
- TLR9 (Toll-Like Receptor 9 (TLR9))
- Andere Bezeichnung
- Tlr9 (TLR9 Produkte)
- Hintergrund
- Tlr9 (Toll-like receptor 9) participates in the innate immune response to microbial agents. Tlr9 (Toll-like receptor 9) detects the unmethylated cytidine-phosphate-guanosine (CpG) motifs present in bacterial DNA. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Tlr9 (Toll-like receptor 9) plays a role in defense against sytemic mouse cytomegalovirus infection. Tlr9 (Toll-like receptor 9) binds MYD88 via their respective TIR domains and interacts with CNPY3. Tlr9 (Toll-like receptor 9) belongs to the Toll-like receptor family and contains 26 LRR (leucine-rich) repeats and 1 TIR domain.
- Pathways
- TLR Signalweg, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Toll-Like Receptors Cascades
-
